5Eid H, Geczi L, Magori A, et al . Drug resistance and sensitivity of germ cell testicular tumors : evaluation of clinical relevance of MDR1 / P2gp , P53, and metallothionein (MT) proteins[J]. Anticancer Res, 1998,18 (4c): 3059-3064.
6Yeh JJ, Shu NY, Shu WH , et al. Comparison of chemotherapy response with P-glycoprotein, mullidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer[J] lung,2005,183 (3):177-183.
7Wright S R, Boag A H, Valdimarsson, et al. Immunohistoehemieal deetection of multidrug resistance protein in human lung cancer and normal lung[J]. Clin Cancer Res, 1998,4(9) :2279-2289.
9Kim R,Chi YJnoue H, et al.Expression and relationship between topoi-somerase I and Ⅱ alpha genes in tumor and normal tissues in esophageal, gastric and colon cancels [J]. Anticancer Res,1999,19 (6B) :5393-5398.
10Suganuma K,KubotaT, Saikawa Y , et al. Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray[J]. Cancer Sci, 2003,94(4) :355-359.
7[1]Flens MJ,Zaman GJR,Valk PVD,et al. Tissue distribution of the multidrug resistance protein[J]. Am J Pathel,1996,148(4): 1237.
8[2]Loe DW,Deeley RG,Cole SPC. Biology of the multidrug resistance-associated protein MRP [J]. Euro J Cancer,1996,32(6) :945.
9[3]Lautier D, Canitor Y, Deeley RG, et al. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene[J ]. Biochem Pharm, 1996,52(7) :967.
10[4]Izquierdo MA,Scheffer GL,Flens MJ,et al. Broad distribution of multidrug resistance-related vault lung resistance protein in normal tissues and tumors [J ]. Am J Pathol,1996,148(3) :877.
7Woodcock TM. Colorectal cancer chemotherapy. J Ky Med Assoc 2009; 107:93-94.
8Bandres E, Zarate R, Ramirez N, Abajo A, Bitarte N, Gariia-Foncillas J. Pharmacogenomics in colorectal cancer: the first step for individualized-therapy, World J Gastroentero12007; 13:5888-5901.
9Tsavaris N, Lazaris A, Kosmas C, Gouveris P, Kavantzas N, Kopterides P, Papathomas T, Agrogiannis G, Zorzos H, Kyriakou V, Patsouris E. Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy. Cancer Chemother Pharmaco12009; 64:391-398.
10Pohl A, Lenz HJ. Individualization of therapy for colorectal cancer based on clinical and molecular parameters. Gastrointest Cancer Res 2008; 2:S38-S41.
